N/A
Completed N=102
Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil
Laryngismus
Source: ClinicalTrials.gov NCT01456299 ↗
Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Apr 2014
Primary outcomePrimary: LMA Insertion Condition — 14; 21; 24; 7 participants
Summary
The purpose of this study was to determine the most suitable effect-site concentration of remifentanil for the LMA insertion during inhaled induction with 8% sevoflurane in adults.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY LMA Insertion Condition |
14; 21; 24; 7; 5; 3 | — |
| SECONDARY Frequency of Apnea |
— | — |
Eligibility Criteria
Inclusion Criteria
- Adult patients, aged 18-60 with ASA physical status I or II, who were scheduled to minor elective surgery ( 30 kg/m2) and suspected difficult airway
Data sourced from ClinicalTrials.gov (NCT01456299). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.